Bilcare Limited (BOM:526853)
68.00
+0.29 (0.43%)
At close: Jan 20, 2026
Bilcare Revenue
Bilcare had revenue of 1.78B INR in the quarter ending September 30, 2025, a decrease of -11.67%. This brings the company's revenue in the last twelve months to 7.57B, down -1.84% year-over-year. In the fiscal year ending March 31, 2025, Bilcare had annual revenue of 7.88B with 5.47% growth.
Revenue (ttm)
7.57B
Revenue Growth
-1.84%
P/S Ratio
0.21
Revenue / Employee
97.01M
Employees
78
Market Cap
1.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 7.88B | 408.57M | 5.47% |
| Mar 31, 2024 | 7.47B | -2.34B | -23.88% |
| Mar 31, 2023 | 9.82B | 1.37B | 16.21% |
| Mar 31, 2022 | 8.45B | 2.22B | 35.65% |
| Mar 31, 2021 | 6.23B | -12.04B | -65.92% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Parnax Lab | 2.05B |
| Ambalal Sarabhai Enterprises | 1.97B |
| Sat Kartar Shopping | 1.63B |
| Lactose (India) | 1.37B |
| Astonea Labs | 1.17B |
| Oxygenta Pharmaceutical | 1.12B |
| Aayush Wellness | 1.11B |
| Quest Laboratories | 1.10B |